Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Trumball, Connecticut 06611


Purpose:

The purpose of this clinical research study is to determine the safety and effectiveness of an experimental drug called rilonacept in subjects with gout who are beginning allopurinol treatment for gout. Subjects will participate in this study for approximately 22 weeks. Rilonacept is being studied for use in preventing allopurinol-induced gout flares.


Criteria:

Inclusion Criteria: - Male or female 18 to 80 years of age - Previously met the preliminary criteria of the ARA for the classification of the acute arthritis of primary gout - At least 2 gout flares in the year prior to the Screening Visit - Serum uric acid greater than or equal to 7.5 mg/dL at the Screening Visit Exclusion Criteria: - Acute gout flare within 2 weeks of the Screening Visit or during Screening - Persistent chronic or active infections - History of an allergic reaction to allopurinol - History or presence of cancer within 5 years of the Screening Visit - Previous exposure to rilonacept - Use of allopurinol, benzbromarone, febuxostat, probenecid or sulfinpyrazone within 3 months prior to the Screening Visit


NCT ID:

NCT00829829


Primary Contact:

N/A


Backup Contact:

N/A


Location Contact:

Trumball, Connecticut 06611
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.